GRAL · GRAIL, Inc.

Summary

GRAIL, Inc. issued a press release on February 19, 2026, announcing top-line results from its NHS-Galleri trial, a randomized controlled trial. The filing is furnished under Items 2.02, 8.01, and 9.01, with Exhibit 99.1 containing the press release on fourth quarter and full year 2025 financial results.

Key takeaways

• Press release issued February 19, 2026
• Top-line results from NHS-Galleri randomized controlled trial announced
• Exhibit 99.1: GRAIL Reports Fourth Quarter and Full Year 2025 Financials
• Filing under Item 2.02 (furnished, not filed)
• Item 8.01: Other Events disclosure